Trials / Completed
CompletedNCT03467542
PHIL in the Treatment of Intracranial dAVF.
PHIL dAVF: Study of PHIL® Embolic System In The Treatment of Intracranial Dural Arteriovenous Fistulas
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Microvention-Terumo, Inc. · Industry
- Sex
- All
- Age
- 22 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective, multicenter, single-arm study. Patients with Dural Arteriovenous Fistulas (dAVF) have a few choice for safe treatment. In this study, all patients with qualifying dAVFs will be treated with PHIL® Liquid Embolic material.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PHIL® Liquid Embolic System | The PHIL Embolic System is indicated in the treatment of dural arteriovenous fistulas (DAVF) |
Timeline
- Start date
- 2018-08-24
- Primary completion
- 2022-12-12
- Completion
- 2022-12-12
- First posted
- 2018-03-16
- Last updated
- 2024-12-31
- Results posted
- 2024-12-31
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03467542. Inclusion in this directory is not an endorsement.